United States Ulcerative Colitis Treatment Market Expected To Reach $11.1 Billion By 2031 - Abbott Laboratories, Ajinomoto, AstraZeneca Plc., Eli-Lilly, GlaxoSmithKline Plc

The Global Ulcerative Colitis Treatment Market reached US$ 6.9 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 11.1 billion by 2031. The global ulcerative colitis treatment market is expected to exhibit a CAGR of 6.3% during the forecast period (2024-2031).

Ulcerative colitis treatment involves medical approaches aimed at reducing inflammation, managing symptoms, and promoting long-term remission in individuals with this chronic inflammatory bowel disease. Treatment options include anti-inflammatory drugs, immunosuppressants, biologic therapies (such as monoclonal antibodies), and in severe cases, surgery to remove the colon. The choice of treatment depends on the severity and extent of the disease and individual patient response.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Ulcerative Colitis Treatment Market Landscape:- https://datamintelligence.com/download-sample/ulcerative-colitis-treatment-market?rk

☛ Ulcerative Colitis Treatment Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In July 2025, Abivax announced positive Phase 3 results from both ABTECT 8-week induction trials for obefazimod, a novel oral therapy for ulcerative colitis. The trials demonstrated a 16.4% advantage over placebo in achieving clinical remission, with a favorable safety profile.

✅ In June 2025, Pfizer launched Velsipity (etrasimod) in the U.S. for the treatment of ulcerative colitis. This approval marks a significant advancement in the availability of targeted therapies for UC patients.

✅ In August 2025, Takeda Pharmaceuticals announced the launch of LIALDA Tablets 600mg, a treatment for ulcerative colitis. This launch provides an additional option for patients managing UC.

Japan: Recent Industry Developments

✅ In July 2025, Mochida Pharmaceutical Co., Ltd. began marketing LIALDA Tablets 600mg for ulcerative colitis. The launch expands treatment options for UC patients in Japan.

✅ In June 2025, Pfizer received approval for Velsipity (etrasimod) in Japan for the treatment of ulcerative colitis, enhancing access to advanced therapies.

✅ In May 2025, Jansen Pharmaceutical announced investment in a new clinical study for an oral UC therapy, aiming to improve remission rates and patient outcomes.

☛ Ulcerative Colitis Treatment Market Competitve Landscape:

Abbott Laboratories, Ajinomoto, AstraZeneca Plc., Eli-Lilly, GlaxoSmithKline Plc., Index Pharmaceuticals Holdings AB, Johnson & Johnson, Merck & Co., Pfizer Inc., and Sanofi,

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/ulcerative-colitis-treatment-market

☛ Segment Covered in the Ulcerative Colitis Treatment Market:

By Type: Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, Fulminant Colitis

By Drug Class: Immunosuppressant, Anti-Inflammatory Drugs, Anti-TNF biologics, Calcineurin Inhibitors, Others

By Route of Administration: Oral, Injectable

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Ulcerative Colitis Treatment Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=ulcerative-colitis-treatment-market

☛ Regional Analysis for Ulcerative Colitis Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Ulcerative Colitis Treatment Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Ulcerative Colitis Treatment Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Ulcerative Colitis Treatment Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.